Description
C19 REAGENTS
First action · last action
2022-03-11 · 2022-03-11
Transactions
1
First transaction's obligation
$245,257
Base + all options value (sum of deltas)
$245,257
Extent competed
COMPETED UNDER SAP
Other than full & open authority
—
Set-aside
NO SET ASIDE USED.
Offers received
1
SDVOSB flag on record
No
Parent IDV
36C25522A0016
NAICS
339112 · SURGICAL AND MEDICAL INSTRUMENT MANUFACTURING
Modification chain · 1 transaction
Each row is one published transaction. This action is the obligation recorded on that transaction — a change amount, as USAspending publishes it. Running total is computed by Glassbox VA as the cumulative sum of those amounts up to and including the row, so the last running total equals the award's net obligations shown above. The cumulative-total columns in the source files are not used: they are not frozen per modification.
- Base2022-03-11+$245,257= $245,257
| Transaction | Action date | This action (delta) | Running total | Description on this transaction |
|---|---|---|---|---|
| Base | 2022-03-11 | +$245,257 | $245,257 | C19 REAGENTS |
Related awards · 11
Awards are related by an explicit link in the data, stated for each group below — never by text similarity. Values are net obligations.
Other VA awards to the same recipient (UEI DP4CNEMUF5F3)
| Award | Office · PSC / listing | Net obligations | FY |
|---|---|---|---|
| 36C25926N0457 | NETWORK CONTRACT OFFICE 19 (36C259) · 6550 · IN VITRO DIAGNOSTIC SUBSTANCES, REAGENTS, TEST KITS AND SETS | $147,256 | FY2026 |
| 36C25926N0454 | NETWORK CONTRACT OFFICE 19 (36C259) · 6640 · LABORATORY EQUIPMENT AND SUPPLIES | $114,883 | FY2026 |
| 36C25726N0477 | 257-NETWORK CONTRACT OFFICE 17 (36C257) · 6550 · IN VITRO DIAGNOSTIC SUBSTANCES, REAGENTS, TEST KITS AND SETS | $337,374 | FY2026 |
| 36C25726D0094 | 257-NETWORK CONTRACT OFFICE 17 (36C257) · 6550 · IN VITRO DIAGNOSTIC SUBSTANCES, REAGENTS, TEST KITS AND SETS | $0 | FY2026 |
| 36C24526P0552 | 245-NETWORK CONTRACT OFFICE 5 (36C245) · 6550 · IN VITRO DIAGNOSTIC SUBSTANCES, REAGENTS, TEST KITS AND SETS | $98,508 | FY2026 |
| 36C24126N0587 | 241-NETWORK CONTRACT OFFICE 01 (36C241) · 6550 · IN VITRO DIAGNOSTIC SUBSTANCES, REAGENTS, TEST KITS AND SETS | $2,457 | FY2026 |
Other recipients under 6640 from 255-NETWORK CONTRACT OFFICE 15 (36C255) (most recent first)
| Award | Recipient | Office | Net obligations | FY |
|---|---|---|---|---|
| 36C25526A0038 | SIEMENS HEALTHCARE DIAGNOSTICS INC. | 255-NETWORK CONTRACT OFFICE 15 (36C255) | $0 | FY2026 |
| 36C25526N0419 | SIEMENS HEALTHCARE DIAGNOSTICS INC. | 255-NETWORK CONTRACT OFFICE 15 (36C255) | $206,949 | FY2026 |
| 36C25526N0374 | ABBOTT LABORATORIES INC. | 255-NETWORK CONTRACT OFFICE 15 (36C255) | $881,319 | FY2026 |
| 36C25526N0387 | ABBOTT LABORATORIES INC. | 255-NETWORK CONTRACT OFFICE 15 (36C255) | $165,764 | FY2026 |
| 36C25526N0379 | WERFEN USA LLC | 255-NETWORK CONTRACT OFFICE 15 (36C255) | $671,956 | FY2026 |
Cite as: Glassbox VA record view · VA contract (USAspending / FPDS) · CONT_AWD_36C25522N0192_3600_36C25522A0016_3600 · retrieved 2026-09-26.